Amazentis
Food & Beverage · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
SwitzerlandWebsite
www.mitopure.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Amazentis
Mitopure is a Swiss-based company that offers the first clinically tested Urolithin A supplement, designed to energize cells and improve muscle strength and endurance. Their proprietary product is derived from pomegranates and provides a highly pure form of Urolithin A, which is difficult to obtain in sufficient amounts through diet alone. Targeting age-related mitochondrial decline, Mitopure supports muscle health, cellular energy, immune function, and skin health, making it suitable for mid-life and older adults. The brand is recognized for its exceptional safety, quality, and efficacy, being the #1 doctor-recommended Urolithin A brand available today.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amazentis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Amazentis had a recent Job posting/layoffs
Check out if Amazentis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Amazentis
Check if Amazentis has recently received funding, and reach out quickly before it becomes old news!
Amazentis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Amazentis has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Amazentis launches new products
Earning: See what the market has to say on Amazentis recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Amazentis as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Amazentis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amazentis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amazentis.
Amazentis Tech Stack
A closer look at the technologies used by Amazentis
See more technologies
Amazentis News & Media
New Milestone Clinical Study Shows Postbiotic Urolithin A (Mitopure™) Improves Muscle Strength and Exercise Performance in Middle Aged Adults
LAUSANNE, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed clinical and translational journal Cell Reports Medicine published new clinical results showing the muscle health benefits of the gut microbiome postbiotic Urolithin A. Age-associated muscle decline can start as early as 40 years old and there are currently noAmazentis Pioneers First Sports Nutrition Program with Mitopure™ (Urolithin A)
LAUSANNE, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Amazentis, an innovative Swiss life sciences company pioneering scientific breakthroughs in nutrition, announced today the initiation of a randomized, double-blinded, placebo-controlled clinical trial in top athletes. The study will take place at the Australian Catholic University with principal investigator, Professor Louise Burke OAM PhD APD, Chair of Sports Nutrition at the Mary MacKillop Institute for Health Research. This follows the アマゼンティスが細胞栄養における画期的成果であるMitopure™を配合したタイムラインを発売
スイス・ローザンヌ & サンフランシスコ--(BUSINESS WIRE)---- （ビジネスワイヤ） -- 先駆的なライフサイエンス企業であるアマゼンティスは本日、タイムライン・セルラー・ニュートリション（Timeline Cellular Nutrition）について、新しい臨床知見と米国での発売を発表します。タイムライン・ニュートリションは、一流の科学者と医師による10年間の研究に基づくものであり、高純度のウロリチンAであるMitopure™を提供する初のブランドとなります。これは加齢に伴う細胞の衰退を防ぎ、筋力を改善することが実証済みです。 健康な中年の参加者（40〜65歳）を対象としたランダム化二重盲検プラセボ対照臨床試験（NCT03464500）により、500 mgのMitopure™（高純度のウロリチンA）を4カ月間にわたり毎日摂取すると、脚筋力の有意な改善がもたらされることが示された。 米国の健康な成人（18〜80歳）を対象に実施された別のランダム化臨床試験（NCT04160312）では、Mitopure™とザクロジュースの摂取後のウロリチンA濃度が比較された。Samenvatting: Amazentis lanceert Timeline ™, mogelijk gemaakt door Mitopure ™ een doorbraak in cellulaire voeding
LAUSANNE, Zwitserland & SAN FRANCISCO--(BUSINESS WIRE)--Het baanbrekende life sciences-bedrijf Amazentis kondigt vandaag nieuwe klinische bevindingen aan en de commerciële lancering van Timeline Cellular Nutrition in de Verenigde Staten. Na een decennium van onderzoek door vooraanstaande wetenschappers en artsen, is Timeline Nutrition het eerste merk dat Mitopure ™ aanbiedt, een zeer zuivere vorm van Urolithine A waarvan bewezen is dat het helpt bij het tegengaan van leeftijdsgebonden cellul
Read more news
Top Food & Beverage Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amazentis
Sign Up For FreeTo access detailed company insights
Mitopure is a Swiss-based company that offers the first clinically tested Urolithin A supplement, designed to energize cells and improve muscle strength and endurance. Their proprietary product is derived from pomegranates and provides a highly pure form of Urolithin A, which is difficult to obtain in sufficient amounts through diet alone. Targetin... Read More
